Adjuvant methylprednisolone lacks efficacy in Guillain-Barré syndrome

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1421, 2004-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccines and Guillain-Barré Syndrome

By Haber Penina  

Drug Safety, Vol. 32, Iss. 4, 2009-01 ,pp. : 309-323

Adis International

Access to resources Recommend Favorite

Guillain-Barré syndrome

By Pritchard Jane  

Clinical Medicine, Vol. 10, Iss. 4, 2010-08 ,pp. : 399-401

Royal College Of Physicians

Access to resources Recommend Favorite

Guillain-Barré Syndrome: Epidemiology, Pathophysiology and Management

By Kuwabara S.  

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 597-610

Adis International

Access to resources Recommend Favorite

Major Surgery with Guillain–Barré Syndrome: a Case Report

By Koc M   Ozalp N   Zulfikaroglu B  

The Journal of International Medical Research, Vol. 30, Iss. 6, 2002-11 ,pp. : 601-604

Field House Publishing

Access to resources Recommend Favorite

Efalizumab: Guillain-Barré syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1321, 2010-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite